Increased gene expression of plasminogen activators and inhibitors in left ventricular hypertrophy

Molecular and Cellular Biochemistry

Volumn 176, Issue 1-2, 1997, Pages 265-271

  Bloor, Colin M ^a,b   Nimmo, Lana ^a   Dan McKirnan, M ^a   Zhang, Y ^a   White, Francis C ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Gene expression; Left ventricular hypertrophy; Plasminogen activator inhibitors; Plasminogen activators; Pressure overload

Indexed keywords

PLASMINOGEN ACTIVATOR; PLASMINOGEN ACTIVATOR INHIBITOR; PLASMINOGEN ACTIVATOR INHIBITOR 1; PLASMINOGEN ACTIVATOR INHIBITOR 2; TISSUE PLASMINOGEN ACTIVATOR; UROKINASE;

ANGIOGENESIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; AORTA CONSTRICTION; AORTA PRESSURE; AORTA VALVE; ARTICLE; ASCENDING AORTA; CONGESTIVE HEART FAILURE; CONTROLLED STUDY; GEL ELECTROPHORESIS; GENE EXPRESSION; HEART FAILURE; HEART LEFT VENTRICLE HYPERTROPHY; HEART LEFT VENTRICLE OVERLOAD; HEART RIGHT VENTRICLE; NONHUMAN; NORTHERN BLOTTING; SWINE; SYSTOLIC BLOOD PRESSURE; TISSUE SECTION;

ANIMALS; GENE EXPRESSION; HEART FAILURE, CONGESTIVE; HYPERTROPHY, LEFT VENTRICULAR; PLASMINOGEN ACTIVATOR INHIBITOR 1; PLASMINOGEN ACTIVATOR INHIBITOR 2; PLASMINOGEN ACTIVATORS; RNA; STROKE VOLUME; SWINE; UP-REGULATION;

ANIMALIA; SUS SCROFA;

EID: 0030777537     PISSN: 03008177     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1006813531576     Document Type: Article

References (27)

1. Ragno P, Montouri N, Vassalli JD, Rossi G: Procession of complex between urokinase and its type 2 inhibitor on the cell surface. A possible regulatory mechanism of urokinase activity. FEBS Lett 323: 279-284, 1993
2. Motz WH, Scheler S, Strauer BE: Medical repair of hypertensive left ventricular remodeling. J Cardiovasc Pharmacol 20: S32-S36, 1992
3. Weber KT, Brilla CG: Myocardial fibrosis and the renin-angiotensin- aldosterone system. J Cardiovasc Pharmacol 20: S48-S54, 1992
4. Flangan MF, Fujii AM, Colan SD, Flangan RG, Lock JE: Myocardial angiogenesis and coronary perfusion in left ventricular pressure- overload hypertrophy in the young lamb: evidence for inhibition with chronic protamine administration. Circ Res 68: 1458-1470, 1991
5. Anversa P, Capasso J: Cardiac hypertrophy and ventricular remodeling (editorial). Lab Invest 64: 441-445, 1991
6. Keeto M, Eguchi Y, Sawdey M, Ahn C, Loskutoff DJ: Cellular localization of type 1 plasminogen activator inhibitor messenger RNA and protein in murine renal tissue. Am J Path 142: 59-70, 1993
7. Kwaan HC: The biologic role of components of the plasminogen- plasmin system. Cardiovasc Dis 5: 309-316, 1992
8. Chomczynski P, Sacchi N: Single-step method of RNA isolation by acid guanidium thiocyanate-phenol-chloroform extraction. Anal Biochem 162: 156-159, 1987
9. Zeheb R, Gelehrter TD: Cloning and sequencing of cDNA for the rat plasminogen activator inhibitor- 1. Gene 73: 459-468, 1988
10. Chow LH, Yee SP, McManus BM: Progressive cardiac fibrosis and myocyte injury in v-fps transgenic mice: a model for primary disorders of connective tissue in the heart. Lab Invest 64: 457-462, 1991
11. Rickles RJ, Strickland S: Tissue plasminogen activator mRNA in murine tissues. FEBS Lett 229: 100-106, 1988
12. Rakusan K, Flanagan MF, Geva T, Southern J, Van Praagh R: Morphometry of human coronary capillaries during normal growth and the effect of age in left ventricular pressure-overload hypertrophy. Circulation 86: 38-46, 1992
13. White FC, Nimmo LM, Nakatani Y, Bloor CM: Compensatory angiogenesis during progressive right ventricular hypertrophy. Am J Cardiovasc Path 4, No. 1:51-68, 1992
14. Santell L, Marotti K, Bartfeld NS, Baynham P, Levin EG: Distribution of microtubules inhibits the stimulation of tissue plasminogen activator expression and promotes plasminogen activator inhibitor type 1 expression in human endothelial cells. Exp Cell Res 201: 358-365, 1992
15. Masure S, Opdenakker G: Cytokine-mediated proteolysis in tissue remodeling. Exper 45: 542-549, 1989
16. Stein PD, Marzilli M, Sabbah HN, Lee T: Systolic and diastolic pressure gradients within the left ventricular wall. Am J Physiol 238: 625-630, 1980
17. Chilian WM, Marcus ML: Coronary vascular adaptions to myocardial hypertrophy. Ann Rev Physiol 49: 477-487, 1987
18. Langer DJ, Kuo A, Kariko K, Ahuja M, Klugherz BD, Ivanics KM, Hoxie JA, Williams WV, Liang BT, Cines DB, et al. Regulation of the endothelial cell urokinase-type plasminogen activator receptor: evidence for cyclic AMP-dependent protein kinase C-dependent pathways. Circ Res 72: 330-340, 1993
19. Bugaisky LB, Siegel E, Whalen RG: Myosin isozyme changes in the heart following constriction of the ascending aorta of a 25 day old rat FASEB Lett 161: 230-234, 1983
20. S afar ME, Benessiano JR, Hornsyk AL: Asymmetric septal hypertrophy and bordering hypertension. Int J Cardiol 2: 103-108, 1982
21. Fujii S, Sawa H, Saffitz JE, Lucore CL, Sobel BE: Induction of endothelial cell expression of the plasminogen activator inhibitor type 1 gene by thrombosis in vivo. Circ 86: 2000-2010, 1992
22. Levy D, Garrison RJ, Savage DD, Kannel WB, Castelli WP: Prognostic implications of echocardiographically determined left ventricular mass in the Framingham Heart Study. N Eng J Med 332: 1561-1566, 1990
23. Knoeplfer PS, Bloor CM, Carroll SC: Urokinase plasminogen activator activity is increased in the myocardium during coronary artery occlusion. J Moll Cell Cardiol 27: 1317-1324, 1995
24. Carroll SM, Nimmo LE, Knoepfler PS, White FC, Bloor CM: Gene expression in a swine model of right ventricular hypertrophy: intercellular adhesion molecule, vascular endothelial growth factor and plasminogen activators are upregulated during pressure overload. J Mol Cell Cardiol 27: 1427-1441, 1995
25. Breisch EA, White EC, Bloor CM: Myocardial characteristics of pressure overload hypertrophy: a structural and functional study. Lab Invest 51 No. 3: 333-342, 1984
26. Breisch EA, White EC, Nimmo LE, Bloor CM: Cardiac vasculature and flow during pressure-overload hypertrophy. Am J Physiol 251: H1031-1037, 1986
27. White EC, Carroll SM, Magnet A, Bloor CM: Coronary collateral development in swine after coronary artery occlusion. Circ Res 71: 1490-1500, 1992